Navigation Links
Cadila gets US FDA approval for Promethazine tablets

Cadila Healthcare Ltd has received US Food Drug Administration (US FDA) approval to market Promethazine tablets 12.5 mg, 25 mg and 50 mg in the US.//

Promethazine is an anti-emetic drug, used to treat allergic symptoms and reactions, to cause sedation, to assist in controlling postoperative pain and to control motion sickness.

The company plans to launch the drug in US this year. The US market for this drug is estimated at $116 million. The group had recently received approval to market Ribavirin capsules in the US market through its US subsidiary Zydus Pharmaceuticals Inc, it added.
'"/>




Page: 1

Related medicine news :

1. Zydus Cadila and Kopran in strategic alliance
2. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
3. Cadila to Commence Phase I Clinical Trials On ZYH2
4. Ranbaxy gets US FDA approval for Lisinopril
5. Aurobindo gets U.S. FDA approval for Cephalexin
6. Anti-obesity drugs for FDA approval
7. Grand FDA nod and approval for drug for heart transplant patients
8. OTC sale for Xenical; Diet Drug; gets FDA approval
9. Clarithromycin tablets to be launched in India soon
10. Say no to detox tablets
11. Manic Ecstasy: Man gets Into a Frenzy after a Record Consumption of 40,000 ecstasy tablets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... 23, 2017 , ... The Wound Certification Prep Course ... Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC as ... interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative effort ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The ... facing life-altering and fatal diseases in opposition to the President’s Fiscal Year ... eviscerate care, services, and hope for the most vulnerable among us. , The ...
(Date:3/23/2017)... Marina del Rey, CA (PRWEB) , ... March ... ... version of its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st ... iCode Assurance optimizes and accelerates the coding audit process for all medical chart ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  A new genetic test has been ... individuals who carry HLA-B*15:02 and who ... potentially deadly side effect of certain medications used ... HLA-B*15:02 is strongly associated with life-threatening ... and toxic epidermal necrolysis in patients treated with ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
(Date:3/23/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... it has acquired Agalimmune Ltd., a private UK-based company with ... $6 million upfront payment, of which $3 million is in ... may be made based on development and commercial milestones. ... Agalimmune,s lead ...
Breaking Medicine Technology: